Seeing Is Believing
Currently out of the existing stock ratings of Stephanie Davis, 132 are a BUY (57.89%), 77 are a HOLD (33.77%), 19 are a SELL (8.33%).
Analyst Stephanie Davis, carries an average stock price target met ratio of 80.39% that have a potential upside of 20.02% achieved within 185 days. Previously, Stephanie Davis worked at LEERINK.
Stephanie Davis’s has documented 430 price targets and ratings displayed on 34 stocks. The coverage was on Healthcare, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on DGX, Quest Diagnostics at 01-Oct-2025.
Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for PHR (PHREESIA) at 3/31/2022. The price target of $29 was fulfilled within 1 day with a profit of $2.64 (10.02%) receiving and performance score of 100.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$16
9 months 21 days ago
(07-Jan-2025)
2/3 (66.67%)
$1.01 (6.74%)
79
Hold
$5.75
9 months 21 days ago
(07-Jan-2025)
4/12 (33.33%)
$1.71 (42.33%)
54
Hold
$7.03
$0.01 (0.14%)
$8
9 months 21 days ago
(07-Jan-2025)
4/10 (40%)
$0.17 (2.48%)
139
$5
$-2.02 (-28.77%)
$6
10 months 12 days ago
(16-Dec-2024)
10/13 (76.92%)
$1.6 (47.06%)
44
Hold
$6
$-1.02 (-14.53%)
$7
1 years 18 days ago
(10-Oct-2024)
10/11 (90.91%)
$2.21 (58.31%)
70
Which stock is Stephanie Davis is most bullish on?
What Year was the first public recommendation made by Stephanie Davis?